At the turn of the century, viral manufacturers were facing major headwinds, and the sector was in a rut. Part of the problem was the inability to get enough clinical grade DNA, quickly enough, at the right price point for them to be able to progress through clinical trials.
Plasmids are essential for the development of viral vectors used to manufacture novel gene therapies and viral vaccines. Aldevron is supporting the innovation of drug developers in this space by providing standardized royalty-free, bulk AAV helper and lentiviral packaging plasmids for research and GMP production.
Like many trade shows, conferences and other events this year, the American Society of Gene & Cell Therapy (ASGCT) had to quickly make alternative arrangements for its annual meeting due to COVID-19. To avoid cancelling this highly anticipated event, organizers opted for a virtual conference for speakers, exhibitors and attendees.